InspireMD Financial Statements From 2010 to 2025

NSPR Stock  USD 2.51  0.01  0.40%   
InspireMD's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing InspireMD's valuation are provided below:
Gross Profit
1.5 M
Market Capitalization
76.9 M
Enterprise Value Revenue
7.5915
Revenue
M
Earnings Share
(0.77)
There are over one hundred nineteen available fundamental trends for InspireMD, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to confirm InspireMD's regular fundamental performance against the performance between 2010 and 2025 to make sure the trends are evolving in the right direction. As of 07/23/2025, Market Cap is likely to grow to about 115.8 M. Also, Enterprise Value is likely to grow to about 98.4 M

InspireMD Total Revenue

4.64 Million

Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 194.1 K, Interest Expense of 23.9 K or Selling General Administrative of 8.6 M, as well as many indicators such as Price To Sales Ratio of 14.95, Dividend Yield of 0.0 or PTB Ratio of 3.21. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
  
Build AI portfolio with InspireMD Stock
Check out the analysis of InspireMD Correlation against competitors.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

InspireMD Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets49.1 M46.8 M21.8 M
Slightly volatile
Other Current Liabilities6.7 M6.4 M3.3 M
Slightly volatile
Total Current Liabilities4.4 M7.7 M4.8 M
Pretty Stable
Cash19.9 M18.9 M10.1 M
Slightly volatile
Cash And Short Term Investments36.4 M34.6 M15.5 M
Slightly volatile
Common Stock Shares Outstanding44 M41.9 M7.9 M
Slightly volatile
Liabilities And Stockholders Equity49.1 M46.8 M20.8 M
Slightly volatile
Other Stockholder Equity149.8 M289.6 M145.5 M
Slightly volatile
Total Liabilities7.6 M10.7 M8.3 M
Slightly volatile
Total Current Assets42.5 M40.5 M19.5 M
Slightly volatile
Short and Long Term Debt Total2.9 M2.3 M3.4 M
Slightly volatile
Non Current Assets Total6.6 M6.3 M2.4 M
Slightly volatile
Non Currrent Assets Other1.6 M1.6 M979 K
Very volatile
Net Receivables1.4 M2.3 M1.3 M
Very volatile
Non Current Liabilities Total2.5 MM3.1 M
Slightly volatile
Inventory2.7 M2.6 M1.5 M
Slightly volatile
Property Plant And Equipment Gross7.4 M7.1 M1.9 M
Slightly volatile
Other Liabilities738.6 K1.1 M725.4 K
Slightly volatile
Property Plant And Equipment NetM4.7 M1.5 M
Slightly volatile
Current Deferred Revenue17.1 K18 K80.6 K
Slightly volatile
Accounts Payable797.1 K1.3 M729.1 K
Pretty Stable
Other Current Assets1.1 M1.1 M511.8 K
Slightly volatile
Property Plant EquipmentM2.8 M1.1 M
Slightly volatile
Long Term Debt Total939.6 K989.1 K2.3 M
Slightly volatile
Capital Surpluse157.7 M207.4 M145.5 M
Slightly volatile
Non Current Liabilities Other2.3 M2.2 M1.2 M
Slightly volatile
Deferred Long Term Asset Charges68 K76.5 K83.4 K
Slightly volatile
Warrants219.2 K246.6 K268.9 K
Slightly volatile
Net Invested Capital21.4 M36.1 M12.3 M
Slightly volatile
Net Working Capital20.3 M32.8 M11.7 M
Slightly volatile
Capital Lease Obligations1.7 M2.3 M1.2 M
Slightly volatile

InspireMD Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization194.1 K280 K182.9 K
Slightly volatile
Selling General Administrative8.6 M15.3 M9.3 M
Slightly volatile
Total Revenue4.6 MM4.3 M
Pretty Stable
Other Operating Expenses42.5 M40.5 M20 M
Slightly volatile
Total Operating Expenses36.8 M35 M17 M
Slightly volatile
Research Development14.3 M13.6 M5.4 M
Slightly volatile
Cost Of Revenue3.3 M5.5 MM
Slightly volatile
Selling And Marketing Expenses3.5 M6.1 M3.2 M
Slightly volatile
Non Recurring785.6 K883.8 K963.6 K
Slightly volatile
Interest Income912.1 K1.6 M754.2 K
Pretty Stable
Reconciled Depreciation206.2 K280 K184.5 K
Slightly volatile

InspireMD Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow7.7 M9.6 M7.9 M
Pretty Stable
End Period Cash Flow19.9 M18.9 M9.3 M
Slightly volatile
Depreciation200.4 K280 K183.3 K
Slightly volatile
Stock Based Compensation10.6 M10.1 M4.7 M
Pretty Stable
Issuance Of Capital Stock1.5 M1.6 M17.7 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio14.9515.7329450
Slightly volatile
Days Sales Outstanding129117121
Slightly volatile
Stock Based Compensation To Revenue0.881.44640.8078
Slightly volatile
Capex To Depreciation5.265.00711.7239
Slightly volatile
Inventory Turnover1.892.14122.2689
Pretty Stable
Days Of Inventory On Hand198170186
Slightly volatile
Payables Turnover3.744.38844.41
Pretty Stable
Sales General And Administrative To Revenue2.312.18382.1
Slightly volatile
Research And Ddevelopement To Revenue2.041.94521.1709
Slightly volatile
Capex To Revenue0.210.20.069
Slightly volatile
Cash Per Share0.780.826183.2 K
Slightly volatile
Days Payables Outstanding10983.1746109
Slightly volatile
Income Quality0.580.68330.7122
Slightly volatile
Current Ratio2.715.27753.4812
Slightly volatile
Receivables Turnover2.593.10963.1408
Pretty Stable
Graham Number0.680.760.832
Slightly volatile
Capex Per Share0.03180.03344.3 K
Slightly volatile
Revenue Per Share0.160.167292.9 K
Slightly volatile
Debt To Assets0.04750.04990.2331
Slightly volatile
Operating Cycle327288307
Slightly volatile
Days Of Payables Outstanding10983.1746109
Slightly volatile
Total Debt To Capitalization0.05780.06080.3953
Slightly volatile
Quick Ratio2.494.94283.2024
Slightly volatile
Net Income Per E B T0.80.90.9824
Slightly volatile
Cash Ratio1.52.46371.9151
Very volatile
Cash Conversion Cycle219205197
Pretty Stable
Days Of Inventory Outstanding198170186
Slightly volatile
Days Of Sales Outstanding129117121
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.821.06411.0096
Slightly volatile
Fixed Asset Turnover1.411.48155.3991
Slightly volatile
Debt Ratio0.04750.04990.2331
Slightly volatile
Price Sales Ratio14.9515.7329450
Slightly volatile
Asset Turnover0.140.14970.2643
Slightly volatile

InspireMD Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap115.8 M110.3 M23.2 M
Slightly volatile

InspireMD Fundamental Market Drivers

Forward Price Earnings11.6959
Cash And Short Term Investments34.6 M

InspireMD Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About InspireMD Financial Statements

InspireMD shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although InspireMD investors may analyze each financial statement separately, they are all interrelated. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses on on InspireMD's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue18 K17.1 K
Total RevenueM4.6 M
Cost Of Revenue5.5 M3.3 M
Stock Based Compensation To Revenue 1.45  0.88 
Sales General And Administrative To Revenue 2.18  2.31 
Research And Ddevelopement To Revenue 1.95  2.04 
Capex To Revenue 0.20  0.21 
Revenue Per Share 0.17  0.16 
Ebit Per Revenue(4.78)(5.02)

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.